Aveanna Healthcare (AVAH) Projected to Post Quarterly Earnings on Thursday

Aveanna Healthcare (NASDAQ:AVAH) is projected to announce its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect the company to announce earnings of $0.07 per share and revenue of $578.5710 million for the quarter. Interested persons may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Thursday, November 6, 2025 at 10:00 AM ET.

Aveanna Healthcare (NASDAQ:AVAH) last posted its earnings results on Monday, May 22nd. The company reported $0.04 EPS for the quarter. Aveanna Healthcare had a negative return on equity of 54.56% and a net margin of 0.85%.The firm had revenue of $450.53 million during the quarter.

Aveanna Healthcare Trading Down 1.1%

Shares of AVAH stock opened at $9.31 on Wednesday. The business’s 50-day moving average price is $8.80 and its 200-day moving average price is $6.42. Aveanna Healthcare has a 12 month low of $3.67 and a 12 month high of $10.32. The firm has a market capitalization of $1.94 billion, a price-to-earnings ratio of 116.38 and a beta of 2.04.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Barclays raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $5.50 to $9.50 in a research note on Tuesday, August 19th. JPMorgan Chase & Co. raised Aveanna Healthcare from an “underweight” rating to a “neutral” rating and lifted their price target for the company from $6.00 to $10.00 in a research note on Thursday, September 18th. UBS Group lifted their price target on Aveanna Healthcare from $8.00 to $9.00 and gave the company a “neutral” rating in a research note on Monday, October 13th. Truist Financial cut their price target on Aveanna Healthcare from $6.00 to $5.00 and set a “hold” rating on the stock in a research note on Wednesday, July 16th. Finally, Royal Bank Of Canada lifted their price objective on Aveanna Healthcare from $8.00 to $10.00 and gave the stock a “sector perform” rating in a research note on Friday, October 24th. Three analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $9.29.

Insider Buying and Selling at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder Robert M. Williams, Jr. sold 10,000,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 21st. The stock was sold at an average price of $9.00, for a total value of $90,000,000.00. Following the transaction, the insider directly owned 386,284 shares of the company’s stock, valued at approximately $3,476,556. The trade was a 96.28% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Paul R. Vigano sold 10,000,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 21st. The shares were sold at an average price of $9.00, for a total value of $90,000,000.00. Following the completion of the transaction, the insider directly owned 386,284 shares in the company, valued at approximately $3,476,556. This trade represents a 96.28% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 32,597,968 shares of company stock valued at $293,381,712. 7.00% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Aveanna Healthcare

Several institutional investors have recently added to or reduced their stakes in the business. AQR Capital Management LLC lifted its stake in Aveanna Healthcare by 21.2% in the first quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock valued at $142,000 after buying an additional 4,602 shares during the period. Invesco Ltd. lifted its stake in Aveanna Healthcare by 31.1% in the second quarter. Invesco Ltd. now owns 20,006 shares of the company’s stock valued at $105,000 after buying an additional 4,742 shares during the period. Creative Planning increased its holdings in shares of Aveanna Healthcare by 15.1% during the second quarter. Creative Planning now owns 47,025 shares of the company’s stock valued at $246,000 after acquiring an additional 6,171 shares in the last quarter. Quantbot Technologies LP bought a new stake in shares of Aveanna Healthcare during the second quarter valued at approximately $43,000. Finally, Sei Investments Co. increased its holdings in shares of Aveanna Healthcare by 71.1% during the second quarter. Sei Investments Co. now owns 29,271 shares of the company’s stock valued at $153,000 after acquiring an additional 12,160 shares in the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.